These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 2210813

  • 21. Enhancement of glomerular platelet-derived growth factor beta-receptor tyrosine phosphorylation in hypertensive rats and its inhibition by calcium channel blocker.
    Zhan Y, Kim S, Kawano H, Iwao H.
    Hypertens Res; 2002 Mar; 25(2):295-301. PubMed ID: 12047046
    [Abstract] [Full Text] [Related]

  • 22. Comparison of converting enzyme inhibitor and calcium channel blocker in SHR with nephrotoxic serum nephritis.
    Ohno A, Inagaki C, Honda K, Sugino N.
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):405-10. PubMed ID: 1635285
    [Abstract] [Full Text] [Related]

  • 23. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H, Murata S, Yabana H, Kikkawa K, Sugawara Y, Akimoto Y, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [Abstract] [Full Text] [Related]

  • 24. Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension.
    Wenzel UO, Troschau G, Schoeppe W, Helmchen U, Schwietzer G.
    Hypertension; 1992 Aug; 20(2):233-41. PubMed ID: 1639466
    [Abstract] [Full Text] [Related]

  • 25. Control of hypertension with captopril affords better renal protection as compared with irbesartan in salt-loaded uremic rats.
    Weissgarten J, Berman S, Efrati S, Rapoport M, Modai D, Cohn M, Aladjem M, Galperin E, Averbukh Z.
    Nephron Physiol; 2005 Aug; 101(1):p14-20. PubMed ID: 15925907
    [Abstract] [Full Text] [Related]

  • 26. Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats.
    O'Donnell MP, Kasiske BL, Katz SA, Schmitz PG, Keane WF.
    Hypertension; 1992 Nov; 20(5):651-8. PubMed ID: 1428116
    [Abstract] [Full Text] [Related]

  • 27. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 28. Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF-beta 1 mRNA expression in rats with chronic renal disease.
    Ali SM, Laping NJ, Fredrickson TA, Contino LC, Olson Ba, Anderson K, Brooks DP.
    Pharmacology; 1998 Jul; 57(1):20-7. PubMed ID: 9670209
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist.
    Benigni A, Gagliardini E, Remuzzi A, Corna D, Remuzzi G.
    Am J Pathol; 2001 Nov; 159(5):1743-50. PubMed ID: 11696435
    [Abstract] [Full Text] [Related]

  • 30. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
    Baylis C, Qiu C, Engels K.
    Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
    [Abstract] [Full Text] [Related]

  • 31. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.
    Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF.
    Circ Res; 1988 Feb; 62(2):367-74. PubMed ID: 3338121
    [Abstract] [Full Text] [Related]

  • 32. Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats.
    Karam H, Clozel JP, Bruneval P, Gonzalez MF, Ménard J.
    Hypertension; 1999 Oct; 34(4 Pt 1):673-8. PubMed ID: 10523345
    [Abstract] [Full Text] [Related]

  • 33. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N, Khang S, Wead LM, Blantz RC, Gabbai FB.
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [Abstract] [Full Text] [Related]

  • 34. Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR.
    Dworkin LD, Feiner HD, Parker M, Tolbert E.
    Kidney Int; 1991 Jun; 39(6):1112-7. PubMed ID: 1895665
    [Abstract] [Full Text] [Related]

  • 35. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G.
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [Abstract] [Full Text] [Related]

  • 36. Glucocorticoids amplify glomerular injury in rats with renal ablation.
    García DL, Rennke HG, Brenner BM, Anderson S.
    Am J Hypertens; 1988 Jan; 1(1):54-7. PubMed ID: 3370134
    [Abstract] [Full Text] [Related]

  • 37. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S, Rennke HG, Brenner BM.
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [Abstract] [Full Text] [Related]

  • 38. The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor.
    Jackson B, Johnston CI.
    J Hypertens; 1988 Jun; 6(6):495-501. PubMed ID: 2842393
    [Abstract] [Full Text] [Related]

  • 39. Renoprotective effect of angiotensin-converting enzyme inhibitor combined with alpha1-adrenergic antagonist in spontaneously hypertensive rats with renal ablation.
    Kanazawa M, Kohzuki M, Kurosawa H, Minami N, Ito O, Saito T, Yasujima M, Abe K.
    Hypertens Res; 2004 Jul; 27(7):509-15. PubMed ID: 15302988
    [Abstract] [Full Text] [Related]

  • 40. Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure.
    Yoshida K, Kohzuki M, Xu HL, Wu XM, Kamimoto M, Sato T.
    J Hypertens; 2001 Mar; 19(3):503-10. PubMed ID: 11288821
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.